-
Huntingtin in health and disease.
Neurology Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. young@helix.mgh.harvard.edu
PMID: 12569151 [PubMed - indexed for MEDLINE]
PMCID: PMC151871
-
Cited by 3 PubMed Central articles
-
ReviewThe corticostriatal pathway in Huntington's disease.
Cepeda C, Wu N, André VM, Cummings DM, Levine MS.
Prog Neurobiol. 2007 Apr; 81(5-6):253-71. Epub 2006 Dec 13.
[Prog Neurobiol. 2007]
-
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, et al.
J Clin Invest. 2006 May; 116(5):1410-24. Epub 2006 Apr 6.
[J Clin Invest. 2006]
-
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
Nguyen T, Hamby A, Massa SM.
Proc Natl Acad Sci U S A. 2005 Aug 16; 102(33):11840-5. Epub 2005 Aug 8.
[Proc Natl Acad Sci U S A. 2005]